Sankalp India Foundation's proactive hemoglobinopathy prevention program averts 201 affected births, offering hope for a healthier future.

CRISPR technology is transforming modern medicine by enabling precise DNA editing to treat genetic disorders, including sickle cell anemia and beta-thalassemia, experts say.

Whales with a lot of money to spend have taken a noticeably bearish stance on Vertex Pharmaceuticals. If we consider the specifics of each trade, it is accurate to state that 9% of the investors ...

Gabriella Ngang, of Farmington Hills, is one of three in Michigan to take part in a clinical trial of a new sickle cell ...

R are genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend ...

PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded ...

Regenerative medicine is gaining serious momentum in 2025 as scientific advances, regulatory progress, and payer acceptance converge to push the sect ...

Mary Jo Fasani was a nurse at Banner Thunderbird Medical Center in Glendale for 24 years, dedicating herself to the medical ...

A team at the Peter Mac is planning for first-in-human trials in five years, hoping this new therapy will eschew the ...

Cartesian's mRNA-based cell therapy offers a novel, outpatient approach for autoimmune diseases. Promising results, but Phase ...

Each of these 10 businesses offers a market-leading product or service within an industry that's set to explode.